AlphaSense
alpha-sense.comDeveloper of web-based financial and company search engine designed to find critical information.
Price per share
12M · USD
Funding history
$M raised · $B post-money
Signals
4 latest
AlphaSense launches SuperAnalyst, an always-on autonomous AI agent that executes financial and strategic workflows
AlphaSense announced SuperAnalyst on 6 October 2026, an always-on, autonomous AI agent that plans, executes, monitors and updates multi-step financial and strategic workflows on top of the company's library of filings, earnings calls, broker research, channel checks and 300,000 proprietary expert interviews. The agent targets workflows such as portfolio monitoring, M&A diligence, market assessment and competitive intelligence for customers the company names including Bank of America, J.P. Morgan, Morgan Stanley, Google, Microsoft, Nvidia and Pfizer. Moving from search to automated workflow execution expands AlphaSense's addressable spend per enterprise customer.
Source: AlphaSense
AlphaSense adds over 10,000 investment banking users in Q3 as 6 more of the top 10 investment banks adopt it
On 6 October 2026 AlphaSense said an additional 6 of the world's 10 largest investment banks selected it in its most recent quarter, taking it to 18 of the world's 20 leading investment banks. The company disclosed over 10,000 new investment banking users added in Q3 and investment banking annual recurring revenue growing 75% year-over-year, across more than 100 investment banks and 8,000 enterprise customers. Disclosed seat and ARR growth in its fastest-growing segment is a direct read on AlphaSense's enterprise revenue trajectory.
Source: AlphaSense
AlphaSense launches Clinical Trial and Drug Data, extending its Life Sciences platform into trials and regulatory data
AlphaSense announced on 15 September 2026 a Clinical Trial and Drug Data offering for its Life Sciences platform, connecting companies, drugs, indications, trials, targets and mode of action into a single knowledge graph for AI-powered workflow execution. The release went out through GlobeNewswire and the company's own press page the same morning; no pricing, customer count or revenue contribution was disclosed. It deepens AlphaSense's second vertical beyond financial-market research, supporting its ARR growth story.
Source: AlphaSense
AlphaSense Study Finds Anthropic and OpenAI Models Can Be Cheaper Than Chinese AI
AlphaSense released a study challenging the assumption that Chinese-made AI models are cheaper, finding that proprietary models from OpenAI and Anthropic can actually be less expensive for certain tasks compared to open-weight models from leading Chinese developers.
Source: theinformation
Explore related companies
More company profiles from the LBX Pro directory.